menu search

VXRT / Vaxart to Host Conference Call on September 1 at 8:30 AM ET to Discuss Top-line Results from Its Phase II COVID-19 Trial

Vaxart to Host Conference Call on September 1 at 8:30 AM ET to Discuss Top-line Results from Its Phase II COVID-19 Trial
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced it will release top-line data from the first part of its planned two-part COVID-19 Phase II trial of its Wuhan S-only construct before the market open on Thursday, September 1, 2022. The Vaxart senior management team will host a live conference call and webcast beginning at 8:30 a.m. Eastern Time on the same date to review the data and provide a trial update. Read More
Posted: Aug 31 2022, 16:30
Author Name: GlobeNewsWire
Views: 111411

VXRT News  

Vaxart, Inc. (VXRT) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 2, 2023

Vaxart, Inc. (VXRT) Q3 2023 Earnings Call Transcript

Vaxart, Inc. (NASDAQ:VXRT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Andrei Floroiu - President and CEO James more_horizontal

Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19

By GlobeNewsWire
October 11, 2023

Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Sci more_horizontal

Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now

By Zacks Investment Research
August 15, 2023

Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for VAXART, INC. (VXRT), indicating that the stock has found support. more_horizontal

Vaxart, Inc. (VXRT) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 3, 2023

Vaxart, Inc. (VXRT) Q2 2023 Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:01 PM ET Vaxart, Inc. (NASDAQ:VXRT ) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 PM ET Company Partici more_horizontal

VAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 3, 2023

VAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue Estimates

VAXART, INC. (VXRT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. more_horizontal

Why Is Vaxart (VXRT) Stock Down 25% Today?

By InvestorPlace
June 7, 2023

Why Is Vaxart (VXRT) Stock Down 25% Today?

Vaxart (NASDAQ: VXRT ) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. According more_horizontal

These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge

By The Motley Fool
April 24, 2023

These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge

Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and s more_horizontal

Vaxart, Inc. (VXRT) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 15, 2023

Vaxart, Inc. (VXRT) Q4 2022 Earnings Call Transcript

Vaxart, Inc. (NASDAQ:VXRT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Brant Biehn - Senior Vice President, Busin more_horizontal


Search within

Pages Search Results: